Chemical Compound Review:
Noxafil 4-[4-[4-[4-[[(5S)-5-(2,4- difluorophenyl)-5...
Synonyms:
SureCN37449, HSDB 7421, LS-186118, LS-186988, LS-187630, ...
Wexler,
Courtney,
Richards,
Banfield,
Lim,
Laughlin,
Greenberg,
Mullane,
van Burik,
Raad,
Abzug,
Anstead,
Herbrecht,
Langston,
Marr,
Schiller,
Schuster,
Wingard,
Gonzalez,
Revankar,
Corcoran,
Kryscio,
Hare,
Pfaller,
Messer,
Hollis,
Jones,
Doern,
Brandt,
Hajjeh,
Groll,
Walsh,
Patera,
Menzel,
Jackson,
Brieland,
Halpern,
Hare,
Cacciapuoti,
Loebenberg,
Barchiesi,
Spreghini,
Santinelli,
Fothergill,
Pisa,
Giannini,
Rinaldi,
Scalise,
Gubbins,
Krishna,
Sansone-Parsons,
Penzak,
Dong,
Martinho,
Anaissie,
Perkhofer,
Lugger,
Dierich,
Lass-Flörl,
Courtney,
Pai,
Laughlin,
Lim,
Batra,
Cuenca-Estrella,
Gomez-Lopez,
Mellado,
Buitrago,
Monzon,
Rodriguez-Tudela,
Al-Abdely,
Najvar,
Bocanegra,
Graybill,
Ghosal,
Hapangama,
Yuan,
Achanfuo-Yeboah,
Iannucci,
Chowdhury,
Alton,
Patrick,
Zbaida,
Sansone-Parsons,
Krishna,
Simon,
Soni,
Kantesaria,
Herron,
Stoltz,
Carrillo-Muñoz,
Quindós,
Ruesga,
Alonso,
del Valle,
Hernández-Molina,
McNicholas,
Loebenberg,
Santos,
Sansone-Parsons,
Krishna,
Calzetta,
Wexler,
Kantesaria,
Rosenberg,
Saltzman,
Kauffman,
Connolly,
Wheat,
Schnizlein-Bick,
Durkin,
Kohler,
Smedema,
Goldberg,
Brizendine,
Loebenberg,
- Clinical efficacy of new antifungal agents. Kauffman, C.A. Curr. Opin. Microbiol. (2006)
- Efficacy of posaconazole in a murine model of central nervous system aspergillosis. Imai, J.K., Singh, G., Clemons, K.V., Stevens, D.A. Antimicrob. Agents Chemother. (2004)
- Pharmacodynamics of a new triazole, posaconazole, in a murine model of disseminated candidiasis. Andes, D., Marchillo, K., Conklin, R., Krishna, G., Ezzet, F., Cacciapuoti, A., Loebenberg, D. Antimicrob. Agents Chemother. (2004)
- Comparison of a new triazole, posaconazole, with itraconazole and amphotericin B for treatment of histoplasmosis following pulmonary challenge in immunocompromised mice. Connolly, P., Wheat, L.J., Schnizlein-Bick, C., Durkin, M., Kohler, S., Smedema, M., Goldberg, J., Brizendine, E., Loebenberg, D. Antimicrob. Agents Chemother. (2000)
- Posaconazole. Keating, G.M. Drugs (2005)
- Posaconazole Enhances the Activity of Amphotericin B against Aspergillus Hyphae In Vitro. Perkhofer, S., Lugger, H., Dierich, M.P., Lass-Flörl, C. Antimicrob. Agents Chemother. (2007)
- Effects of age, gender, and race/ethnicity on the pharmacokinetics of posaconazole in healthy volunteers. Sansone-Parsons, A., Krishna, G., Simon, J., Soni, P., Kantesaria, B., Herron, J., Stoltz, R. Antimicrob. Agents Chemother. (2007)
- Posaconazole prophylaxis in experimental systemic zygomycosis. Barchiesi, F., Spreghini, E., Santinelli, A., Fothergill, A.W., Pisa, E., Giannini, D., Rinaldi, M.G., Scalise, G. Antimicrob. Agents Chemother. (2007)
- Effect of granulocyte colony-stimulating factor combination therapy on efficacy of posaconazole (SCH56592) in an inhalation model of murine pulmonary aspergillosis. Patera, A.C., Menzel, F., Jackson, C., Brieland, J.K., Halpern, J., Hare, R., Cacciapuoti, A., Loebenberg, D. Antimicrob. Agents Chemother. (2004)
- The Anti-Trypanosoma cruzi Activity of Posaconazole in a Murine Model of Acute Chagas' Disease Is Less Dependent on Gamma Interferon than That of Benznidazole. Ferraz, M.L., Gazzinelli, R.T., Alves, R.O., Urbina, J.A., Romanha, A.J. Antimicrob. Agents Chemother. (2007)
- Antifungal activity of posaconazole compared with fluconazole and amphotericin B against yeasts from oropharyngeal candidiasis and other infections. Carrillo-Muñoz, A.J., Quindós, G., Ruesga, M., Alonso, R., del Valle, O., Hernández-Molina, J.M., McNicholas, P., Loebenberg, D., Santos, P. J. Antimicrob. Chemother. (2005)
- Newer triazole antifungal agents: pharmacology, spectrum, clinical efficacy and limitations. Aperis, G., Mylonakis, E. Expert opinion on investigational drugs. (2006)
- Oral bioavailability of posaconazole in fasted healthy subjects: comparison between three regimens and basis for clinical dosage recommendations. Ezzet, F., Wexler, D., Courtney, R., Krishna, G., Lim, J., Laughlin, M. Clinical pharmacokinetics. (2005)
- Disposition of posaconazole following single-dose oral administration in healthy subjects. Krieter, P., Flannery, B., Musick, T., Gohdes, M., Martinho, M., Courtney, R. Antimicrob. Agents Chemother. (2004)
- Pharmacokinetics and safety of oral posaconazole in neutropenic stem cell transplant recipients. Gubbins, P.O., Krishna, G., Sansone-Parsons, A., Penzak, S.R., Dong, L., Martinho, M., Anaissie, E.J. Antimicrob. Agents Chemother. (2006)
- Treatment of cavitary pulmonary zygomycosis with surgical resection and posaconazole. Paul, S., Marty, F.M., Colson, Y.L. Ann. Thorac. Surg. (2006)
- Posaconazole: clinical pharmacology and potential for management of fungal infections. Groll, A.H., Walsh, T.J. Expert review of anti-infective therapy. (2005)
- Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi. Cuenca-Estrella, M., Gomez-Lopez, A., Mellado, E., Buitrago, M.J., Monzon, A., Rodriguez-Tudela, J.L. Antimicrob. Agents Chemother. (2006)
- Antifungal therapy of experimental cerebral phaeohyphomycosis due to Cladophialophora bantiana. Al-Abdely, H.M., Najvar, L.K., Bocanegra, R., Graybill, J.R. Antimicrob. Agents Chemother. (2005)
- In vitro susceptibilities of Candida bloodstream isolates to the new triazole antifungal agents BMS-207147, Sch 56592, and voriconazole. Pfaller, M.A., Messer, S.A., Hollis, R.J., Jones, R.N., Doern, G.V., Brandt, M.E., Hajjeh, R.A. Antimicrob. Agents Chemother. (1998)
- Effect of posaconazole on cytochrome P450 enzymes: a randomized, open-label, two-way crossover study. Wexler, D., Courtney, R., Richards, W., Banfield, C., Lim, J., Laughlin, M. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. (2004)
- Application of real-time quantitative PCR to molecular analysis of Candida albicans strains exhibiting reduced susceptibility to azoles. Chau, A.S., Mendrick, C.A., Sabatelli, F.J., Loebenberg, D., McNicholas, P.M. Antimicrob. Agents Chemother. (2004)
- Identification of human UDP-glucuronosyltransferase enzyme(s) responsible for the glucuronidation of posaconazole (Noxafil). Ghosal, A., Hapangama, N., Yuan, Y., Achanfuo-Yeboah, J., Iannucci, R., Chowdhury, S., Alton, K., Patrick, J.E., Zbaida, S. Drug Metab. Dispos. (2004)
- Posaconazole as salvage therapy for zygomycosis. Greenberg, R.N., Mullane, K., van Burik, J.A., Raad, I., Abzug, M.J., Anstead, G., Herbrecht, R., Langston, A., Marr, K.A., Schiller, G., Schuster, M., Wingard, J.R., Gonzalez, C.E., Revankar, S.G., Corcoran, G., Kryscio, R.J., Hare, R. Antimicrob. Agents Chemother. (2006)
- Pulmonary mucormycosis (zygomycosis) in a lung transplant recipient: recovery after posaconazole therapy. Brugière, O., Dauriat, G., Mal, H., Marrash-Chalha, R., Fournier, M., Groussard, O., Besnard, M., Lesèche, G., Dupont, B. Transplantation (2005)
- Pharmacokinetics, safety, and tolerability of oral posaconazole administered in single and multiple doses in healthy adults. Courtney, R., Pai, S., Laughlin, M., Lim, J., Batra, V. Antimicrob. Agents Chemother. (2003)
- Effect of a Nutritional Supplement on Posaconazole Pharmacokinetics following Oral Administration to Healthy Volunteers. Sansone-Parsons, A., Krishna, G., Calzetta, A., Wexler, D., Kantesaria, B., Rosenberg, M.A., Saltzman, M.A. Antimicrob. Agents Chemother. (2006)